KRAS and leukemia: Among RASmut MLL-AF4 rearranged leukaemia specimens at diagnosis, 69.5% were characterized by ≥2 different clones with a distinct RAS mutation in the mutation hot spot regions, which also means that KRAS and NRAS mutations are not mutually exclusive.